Dünya
Ecza Deposu Medical
Ankaferd Tampon
PRESCRIBING INFORMATION
Unit Formula: 10 ml product contains; Urtica Dioica (dried root extract) 0.6 mg, Vitis Vinifera (dried leaf extract) 0.8 mg, Glycrrhiza Glabra (dried leaf exrtact) 0.9 mg, Alpinia Officinarum (dried leaf extract) 0.7 mg, Thymus Vulgaris (dried grass extract) 0.5 mg.
Medical Properties Ankaferd BloodStopper, a hemorrhage stopping preparation, forms a network inside plazma or serum in a very short time. General haemostatic and biochemical tests have shown that the mentioned network is formed via the interaction between Ankaferd BloodStopper and proteins in blood; but primarily via the product’s interaction with fibrinogen.
The process of stopping hemmorhage is primarily related with protein agglutination. Blood cells too take their part in the network. Independent of the physiological haemostatic process tissue factor related to blood coagulation, Ankaferd BloodStopper, developes without effecting this system.
Therefore Ankaferd BloodStopper is not only effective on patients with normal haemostatic values, but also on those who are primary and secondary hemostaz defective. Ankaferd BloodStopper can be employed as an aide product in clinique procedures for stopping intensive external hemorrhaging, including mucous fissures. Ankaferd BloodStopper must not be injected into vein or blood circulation system.
Leave tampon until the bleeding stops and see your closest health care center. Apply Ankaferd Bloodstopper until it shows effect and stops bleeding and see your closest health center. Cautions/Precautions: Please carefully read prescribing instructions before use. Inform your doctor and pharmacy without fail If taking any medication. Stops external bleeding, has no known side effects, does not cause irritation, is non-toxic, sterile and does not contain alcohol. Conditions where it should not be used: None. Side/Adverse Effects: Ankaferd BloodStopper has no known side effect. If an undesired effect is seen contact Türkiye Farmakovijilans Merkezi (Pharmacovigilance Centre of Turkey) [TÜFAM].
Drug Interaction and Other Interactions: Ankaferd BloodStopper has no known adverse interaction with drugs used by patients. It is hypoallergenic. Administration and Dosage: According to density of bleeding Ankaferd Bloodstopper tampon should be employed in cases of external wounding and traumatic cuts until bleeding stops. If bleeding recommences, product should be applied until bleeding stops. This procedure is repeated 2-3 times until bleeding stops. Each moist tampon is for single use only. Commercial Presentation Form: Ankaferd Bloodstopper, commercial presentation: Product supplied as (2.5cm.x7cm.-3ml.) - (5cm.x7,5cm.-10ml.) - (20cm.x20cm.-100ml.) Each package contains 12 unit ANKAFERD tampon.
Other Commercial Presentation Forms
0216-4612648-49
Gastric Bleeding
Ankaferd Blood Stopper application for Gastric Bleeding
Subcutaneous bleeding model
Ankaferd Blood Stopper In Vivo Experiment
Venous bleeding model
Ankaferd Blood Stopper In Vivo Experiment
Artery bleeding model
Ankaferd Blood Stopper In Vivo Experiment
ABS affect on blood under microscope
Ankaferd Blood Stopper In Vitro Experiment
Bleeding spleen damage model
Ankaferd Blood Stopper In Vivo Experiment